Login / Signup

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D.

Jung-Yun LeeJung Bok LeeMyong Cheol LimByoung-Gie KimJae-Weon KimSunghoon KimChel Hun ChoiHee Seung KimSang Yoon ParkJung-Yun Leenull null
Published in: Journal for immunotherapy of cancer (2023)
NCT03899610.
Keyphrases
  • neoadjuvant chemotherapy
  • phase ii study
  • locally advanced
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • sentinel lymph node
  • lymph node
  • open label
  • clinical trial
  • randomized controlled trial
  • early stage